Medicine - Hematology and Medical Oncology

137 Active
260 Finished

Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer.
Germain, D.
National Cancer Institute
1/01/23 → 31/12/23
Project: Research
Mechanistic understanding of dysregulated iron metabolism in polycythemia vera
Ginzburg, Y. & Hoffman, R.
National Institute of Diabetes and Digestive and Kidney Diseases
20/09/22 → 31/08/23
Project: Research
Machine Learning to Predict Mortality and Improve End-of-Life Outcomes among Minorities with Advanced Cancer
Smith, C.
National Cancer Institute
20/09/22 → 31/08/23
Project: Research
Project 2: Inhibition of RIPK1 Mediated Cell Death to Prevent GVHD
Ferrara, J.
National Cancer Institute
1/07/22 → 30/06/23
Project: Research
Admin Core: Administration, Biostatistics and Data Coordinating Center
Ferrara, J.
National Cancer Institute
1/07/22 → 30/06/23
Project: Research
Project 1: Mitochondrial Bioenergetics and Metabolism of ISCS in GVHD
Ferrara, J.
National Cancer Institute
1/07/22 → 30/06/23
Project: Research
Mount Sinai Medical Scientist Training Program
Baron, M.
National Institute of General Medical Sciences
1/07/22 → 30/06/23
Project: Research
Core 2: Biorepository, Biomarker Analysis and GI Organoids
Ferrara, J.
National Cancer Institute
1/07/22 → 30/06/23
Project: Research
A prognostic mRNA immune signature for resected stage II-III melanoma
Saenger, Y. Y. M. & Saenger, , Y.
National Cancer Institute
1/04/22 → 31/03/23
Project: Research
Investigating the Roles of Patient Beliefs, Stigma, and Physician Implicit Bias on Disparities in Lung Cancer Screening
Kale, M., Smith, C., Kale, M. S. & Smith, C. B.
National Institute on Minority Health and Health Disparities
20/09/21 → 31/05/23
Project: Research
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis
Smalley, K. K., Harbour, J. J. W. & Licht, J.
National Cancer Institute
9/08/21 → 31/07/23
Project: Research
Role of RABL6A-PP2A in neuroendocrine tumors
Quelle, D. D. E., Narla, G., Narla, G. & Quelle, D. E.
National Cancer Institute
1/05/21 → 30/04/23
Project: Research

290747 Citations
233 h-index
4008 Article
677 Review article
250 Letter
202 Comment/debate
More

Back to the future: lessons from development drive innovation of human pluripotent stem cell therapies
Ditadi, A. & Sturgeon, C. M., Jan 2023, In: Experimental Hematology. 117, p. 9-14 6 p.
Research output: Contribution to journal › Review article › peer-review
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support
Mouhieddine, T. H., Moshier, E., Thibaud, S., Puliafito, B., Rattu, M., Jakubowski, R., Sanchez, L., Rossi, A., Rodriguez, C., Richard, S., Cho, H. J., Parekh, S., Chari, A., Steinberg, A. & Richter, J., Jan 2023, In: Bone Marrow Transplantation. 58, 1, p. 80-86 7 p.
Research output: Contribution to journal › Article › peer-review
Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease
Li, H., Kazmi, J. S., Lee, S., Zhang, D., Gao, X., Maryanovich, M., Torres, L., Verma, D., Kelly, L., Ginzburg, Y. Z., Frenette, P. S. & Manwani, D., 12 Jan 2023, In: Blood. 141, 2, p. 194-199 6 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Erratum: Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements (Communications biology (2022) 5 1 (1295))
Kimmerling, R. J., Stevens, M. M., Olcum, S., Minnah, A., Vacha, M., LaBella, R., Ferri, M., Wasserman, S. C., Fujii, J., Shaheen, Z., Sundaresan, S., Ribadeneyra, D., Jayabalan, D. S., Agte, S., Aleman, A., Criscitiello, J. A., Niesvizky, R., Luskin, M. R., Parekh, S., Rosenbaum, C. A., & 2 othersTamrazi, A. & Reid, C. A., 6 Jan 2023, In: Communications Biology. 6, 1, p. 15 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Katz Sand, I., Gnjatic, S., Krammer, F., Tuballes, K., Carreño, J. M., Satyanarayan, S., Filomena, S., Staker, E., Tcheou, J., Miller, A., Fabian, M., Safi, N., Nichols, J., Patel, J., Krieger, S., Tankou, S., Horng, S., Klineova, S., Beck, E., Merad, M., & 1 othersLublin, F., Feb 2023, In: Multiple Sclerosis and Related Disorders. 70, 104486.
Research output: Contribution to journal › Article › peer-review
IGF1R Inhibition Enhances the Therapeutic Effects of Gq/11 Inhibition in Metastatic Uveal Melanoma Progression
Lapadula, D., Lam, B., Terai, M., Sugase, T., Tanaka, R., Farias, E., Kadamb, R., Lopez-Anton, M., Heine, C. C., Modasia, B., Aguirre-Ghiso, J. A., Aplin, A. E., Sato, T. & Benovic, J. L., 3 Jan 2023, In: Molecular Cancer Therapeutics. 22, 1, p. 63-74 12 p.
Research output: Contribution to journal › Article › peer-review
Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm
Tran, J. H., Mhango, G., Park, H. S., Marshall, D. C., Rosenzweig, K. E., Wang, Q., Wisnivesky, J. P. & Veluswamy, R. R., Jan 2023, In: Clinical Lung Cancer. 24, 1, p. e9-e18
Research output: Contribution to journal › Article › peer-review
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Cohen, A. D., Hari, P., Htut, M., Berdeja, J. G., Usmani, S. Z., Madduri, D., Olyslager, Y., Goldberg, J. D., Schecter, J. M., Jackson, C. C., Gries, K. S., Fastenau, J. M., Valluri, S., Deraedt, W., Akram, M., Crawford, R., Morrison, R., Doward, L., Morgan, K., Seldam, S. T., & 2 othersJakubowiak, A. & Jagannath, S., Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 68-77 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
Thompson, M. A., Boccadoro, M., Leleu, X., Vela-Ojeda, J., van Rhee, F., Weisel, K. C., Rifkin, R. M., Usmani, S. Z., Hájek, R., Cook, G., Abonour, R., Armour, M., Morgan, K. E., Yeh, S. P., Costello, C. L., Berdeja, J. G., Davies, F. E., Zonder, J. A., Lee, H. C., Omel, J., & 9 othersSpencer, A., Terpos, E., Hungria, V. T. M., Puig, N., Fu, C., Ferrari, R. H., Ren, K., Stull, D. M. & Chari, A., 2023, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.
Research output: Contribution to journal › Article › peer-review

Open Access
Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma: Clinically advanced CAR-T therapies for RRMM
Martin, T., Jackson, C. C., Pacaud, L., Madduri, D. & Jagannath, S., Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 22-27 6 p.
Research output: Contribution to journal › Short survey › peer-review
Standard Naloxone Prescribing for Palliative Care Cancer Patients on Opioid Therapy: A Single-Site Quality Improvement Pilot to Assess Attitudes and Access
Afezolli, D., Flemig, D., Easton, E., Austin, V., Scarborough, B. & Smith, C. B., 2023, (Accepted/In press) In: Journal of Pain and Symptom Management.
Research output: Contribution to journal › Article › peer-review
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials
Chhabra, S., Callander, N., Watts, N. L., Costa, L. J., Thapa, B., Kaufman, J. L., Laubach, J., Sborov, D. W., Reeves, B., Rodriguez, C., Chari, A., Silbermann, R., Anderson, L. D., Bal, S., Dhakal, B., Nathwani, N., Shah, N., Medvedova, E., Bumma, N., Holstein, S. A., & 17 othersCostello, C., Jakubowiak, A., Wildes, T. M., Schmidt, T., Orlowski, R. Z., Shain, K. H., Cowan, A. J., Dholaria, B., Cornell, R. F., Jerkins, J. H., Pei, H., Cortoos, A., Patel, S., Lin, T. S., Usmani, S. Z., Richardson, P. G. & Voorhees, P. M., 2023, (Accepted/In press) In: Transplantation and Cellular Therapy.
Research output: Contribution to journal › Article › peer-review

Open Access

The Genetics of Multiple Myeloma: Expert Perspectives
Joshua Richter
2/02/23
1 item of Media coverage
Press/Media
Breast Cancer Expert Focuses on Decoding Biomarkers
Joseph Sparano
2/02/23
1 item of Media coverage
Press/Media
Clinical Review of ropeginterferon alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia Vera
John Mascarenhas
2/02/23
2 items of Media coverage
Press/Media
Woman, 36, details rare cervical cancer diagnosis while pregnant with 1st child
Marshall Posner
1/02/23
2 items of Media coverage
Press/Media
Cancer vaccines: Can the disease be treated with an injection?
Nina Bhardwaj
1/02/23
1 item of Media coverage
Press/Media
New Data from Memorial Sloan-Kettering Cancer Center Illuminate Research in Glioblastomas (A phase I trial of VEGF-A inhibition combined with PD-L1 blockade for recurrent glioblastoma)
Jingjing Qi, Tin Htwe Thin, Sacha Gnjatic & John Mandeli
30/01/23
1 item of Media coverage
Press/Media
Cell BioEngines Enters into Licensing Agreement with Icahn School of Medicine at Mount Sinai
Sreekumar Balanalan, Sreekumar Balan & Nina Bhardwaj
27/01/23
1 item of Media coverage
Press/Media
Cilta-Cel May Lower Risk of Disease Progression or Death in R/R Multiple Myeloma
Joshua Richter
27/01/23
1 item of Media coverage
Press/Media
New drugs, if approved, could have big impact in 2023
Ajai Chari
27/01/23
1 item of Media coverage
Press/Media
Top sports advisory for 5 p.m., Jan. 26, 2023
Ronald Blum,
26/01/23
1 item of Media coverage
Press/Media
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
Sreekumar Balanalan, Sreekumar Balan & Nina Bhardwaj
25/01/23 → 26/01/23
93 items of Media coverage
Press/Media
A Tennis Champion Who is Also a Breast Cancer Survivor
Kenneth L. Davis & Hanna Irie
25/01/23
1 item of Media coverage
Press/Media